Orion Group Holdings, Inc
ORN Real Time Price USDRecent trades of ORN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in ORN holdings by institutional investors
Quarterly net insider trading by ORN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$50,000 Oct 18, 2019 Issue: Defense
-
$50,000 Jul 22, 2019 Issue: Defense
ORN Estimated quarterly lobbying spending
ORN Revenue by Segment or Geography
New ORN patent grants
-
Patent Title: Packaging Oct. 07, 2025
-
Patent Title: Packaging Oct. 07, 2025
-
Patent Title: Packaging Jul. 29, 2025
-
Patent Title: Packaging Jul. 15, 2025
-
Patent Title: Packaging Feb. 18, 2025
-
Patent Title: Snack packaging Oct. 08, 2024
-
Patent Title: Snack packaging Sep. 24, 2024
-
Patent Title: Snack packaging Sep. 24, 2024
-
Patent Title: Packaging Aug. 20, 2024
-
Patent Title: Packaging for snack pack Jun. 04, 2024
-
Patent Title: Inhaler May. 16, 2023
-
Patent Title: Inhaler Apr. 04, 2023
-
Patent Title: Inhaler Feb. 07, 2023
-
Patent Title: Packaging Jan. 31, 2023
-
Patent Title: Packaging box Jan. 31, 2023
-
Patent Title: Package for foodstuffs Sep. 27, 2022
-
Patent Title: Packaging Sep. 13, 2022
-
Patent Title: Inhaler Aug. 09, 2022
-
Patent Title: Packaging sheet Jun. 22, 2021
-
Patent Title: Packaging for snack pack Oct. 27, 2020
-
Patent Title: Packaging for snack pack Oct. 20, 2020
-
Patent Title: Packaging for snack pack Oct. 20, 2020
-
Patent Title: Packaging for snack pack Oct. 20, 2020
-
Patent Title: Cyp17 inhibitors/antiandrogens Feb. 13, 2018
-
Patent Title: Androgen receptor modulating compounds May. 23, 2017
-
Patent Title: N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists Jan. 03, 2017
-
Patent Title: Catechol o-methyltransferase activity inhibiting compounds Oct. 04, 2016
-
Patent Title: Protein kinase inhibitors Sep. 20, 2016
-
Patent Title: Alpha2 adrenoceptor agonists Feb. 02, 2016
-
Patent Title: Package Jul. 07, 2015
-
Patent Title: Packing box Apr. 28, 2015
-
Patent Title: Packaging box for confectionery Apr. 07, 2015
-
Patent Title: Androgen receptor modulating compounds Mar. 10, 2015
-
Patent Title: Androgen receptor modulating carboxamides Dec. 30, 2014
-
Patent Title: 2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous system diseases Aug. 19, 2014
-
Patent Title: Packaging sheet for confectionery Jul. 22, 2014
-
Patent Title: Packaging box for confectionery Jul. 15, 2014
-
Patent Title: Packaging box for confectionery Jun. 10, 2014
-
Patent Title: Packing box for confectionery Mar. 25, 2014
-
Patent Title: Packing box for confectionery Jan. 07, 2014
-
Patent Title: Packaging sheet for confectionary Dec. 31, 2013
-
Patent Title: Packaging box for confectionery Mar. 26, 2013
-
Patent Title: Packaging box for confectionery Mar. 26, 2013
-
Patent Title: Packaging box for confectionery Jan. 01, 2013
-
Patent Title: Packing for confectionery Jan. 01, 2013
-
Patent Title: Packaging box for confectionery Nov. 27, 2012
-
Patent Title: Packaging sheet for confectionery Jun. 19, 2012
-
Patent Title: Container for gum Jun. 21, 2011
-
Patent Title: Container for gum Jun. 21, 2011
-
Patent Title: Packaging box for confectionary May. 10, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded to ORN from public contracts
Recent insights relating to ORN
Recent picks made for ORN stock on CNBC
ETFs with the largest estimated holdings in ORN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ORN stock a Buy, Sell, or Hold?
- What is the price target for $ORN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ORN stock?
- Who owns the most shares of $ORN stock?
- What funds own $ORN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ORN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.
- Address Houston, TX
- Market Cap 356.3 million
- Employees 1,887
- Industrial Classification Heavy Construction Other Than Bldg Const - Contractors